ANCA-ASSOCIATED VASCULITIS
Clinical trials for ANCA-ASSOCIATED VASCULITIS explained in plain language.
Never miss a new study
Get alerted when new ANCA-ASSOCIATED VASCULITIS trials appear
Sign up with your email to follow new studies for ANCA-ASSOCIATED VASCULITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on autoimmune diseases in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment called RD06-05, which uses specially engineered immune cells (CAR-T cells) to target and calm overactive immune responses in people with autoimmune diseases like lupus, vasculitis, and scleroderma. The main goal is to check safety and …
Matched conditions: ANCA-ASSOCIATED VASCULITIS
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:25 UTC
-
Immune reset: CAR-T therapy targets lupus and other autoimmune conditions
Disease control Recruiting nowThis early-stage study tests a new treatment using a patient's own immune cells, modified to target and destroy faulty immune cells causing autoimmune diseases like lupus and scleroderma. The goal is to see if this 'reset' is safe and can control disease activity. About 20 adults…
Matched conditions: ANCA-ASSOCIATED VASCULITIS
Phase: EARLY_PHASE1 • Sponsor: Nanjing Bioheng Biotech Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:23 UTC
-
New PET tracer could spot hidden organ damage in rare vasculitis
Diagnosis Recruiting nowThis study explores whether a new type of PET scan tracer can help doctors see lung and kidney problems in people with ANCA-associated vasculitis, a rare autoimmune disease. The tracer targets specific cells linked to tissue scarring. Researchers will scan 30 adults to see if thi…
Matched conditions: ANCA-ASSOCIATED VASCULITIS
Sponsor: Ruijin Hospital • Aim: Diagnosis
Last updated May 22, 2026 14:04 UTC
-
Massive study aims to unravel mysteries of rare blood vessel disease
Knowledge-focused Recruiting nowThis study follows up to 4,000 people with or at risk for vasculitis—a group of diseases that cause blood vessel inflammation—to learn how the condition develops and changes over time. Participants provide blood, urine, and imaging samples, and some have regular check-ups every 3…
Matched conditions: ANCA-ASSOCIATED VASCULITIS
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated May 26, 2026 11:35 UTC